AstraZeneca, BMS, Moderna vaccine, TCGX: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hiya, and welcome back to The Readout. Today, we’re getting ready for the FDA’s upcoming decision on Moderna’s mRNA flu shot, and see both a revived fight over 340B rebates and fresh legal scrutiny…
